Delivery Order SPE2DB24D3015-SPE2DB25FFZDZ

Award Date 4/30/25
Potential Completion Date 5/21/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, ID SPE2DB24D3015|SPE2DB25FFYBH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 delivery order contract is for the supply of CALQUENCE 100 MG TABLET 60S, with a performance period ending on March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 firm fixed-price delivery order is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKGSW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,781.31 firm fixed-price delivery order is for the supply of 4567155602 CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with a period of performance through February 26, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.56 firm fixed-price delivery order is for the supply of 4568078164 - CALQUENCE 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of May 20, 2025 and was awarded on April 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, SPE2DB20D3303|SPE2DB25FZ4V7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 firm-fixed-price delivery order is for the supply of CALQUENCE 100 MG TABLET 60S, with an ultimate completion date of April 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUJ84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.56 Firm Fixed Price Delivery Order contract is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on January 31, 2025. This award is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 firm fixed-price delivery order is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The $8,575.36 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation,...
This federal contract award, valued at $5,593.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA, designated as SPE2DX, which has a total potential value of $999,999,999.00. The delivery order is for the pharmaceutical product CALQUENCE 100 MG TABLET 60S, a prescription medication. The contract has a firm fixed price and does...
This federal contract award, valued at $5,593.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price for the provision of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZDZ
    Delivery Order

This federal contract award, identified as SPE2DB24D3015|SPE2DB25FFZDZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,593.77 firm fixed-price delivery order is for the supply of 4568092533 CALQUENCE 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 8/3/25, 1:28 AM